These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 483249)

  • 1. Ionophoretic activities of phospholipids on human platelets.
    Ikeda Y; Kikuchi M; Toyama K; Watanabe K; Ando Y
    Thromb Haemost; 1979 Jun; 41(4):779-86. PubMed ID: 483249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acids. II. Interaction of the effects of adenosine diphosphate and lysophosphatidic acids in dog, rabbit, and human platelets.
    Gerrard JM; Kindom SE; Peterson DA; White JG
    Am J Pathol; 1979 Dec; 97(3):531-47. PubMed ID: 315721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipids released from activated platelets improve platelet aggregation and endothelial cell migration.
    Xiao H; Siddiqui RA; Al-Hassani MH; Sliva D; Kovacs RJ
    Platelets; 2001 May; 12(3):163-70. PubMed ID: 11304418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dilazep on cytoplasmic calcium ion concentrations and arachidonic acid metabolism in activated human platelets.
    Okuma M; Kanaji K; Sensaki S; Uchino H
    Arzneimittelforschung; 1989 Mar; 39(3):372-5. PubMed ID: 2502990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of phospholipase C on human blood platelets.
    Otnaess AB; Holm T
    J Clin Invest; 1976 Jun; 57(6):1419-25. PubMed ID: 819457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysophosphatidic acids. Influence on platelet aggregation and intracellular calcium flux.
    Gerrard JM; Kindom SE; Peterson DA; Peller J; Krantz KE; White JG
    Am J Pathol; 1979 Aug; 96(2):423-38. PubMed ID: 112871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between enhanced phosphoinositide turnover and cellular responses in platelets from spontaneously hypertensive rats.
    Koutouzov S; Remmal A; Meyer P; Marche P
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S6-9. PubMed ID: 2459517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets.
    Li BY; Bai Y; Li WH
    Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil.
    Han P; Boatwright C; Ardlie NG
    Thromb Haemost; 1983 Aug; 50(2):513-7. PubMed ID: 6314581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative investigation of the effects of the immunosuppressants cyclosporine A, cyclosporine G, and FK-506 on platelet activation.
    Fernandes JB; Naik UP; Markell MS; Kornecki E
    Cell Mol Biol Res; 1993; 39(3):265-74. PubMed ID: 7507391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
    Peerschke EI
    J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactions of polylysine with human platelets in plasma and in suspensions of washed platelets.
    Guccione MA; Packham MA; Kinlough-Rathbone RL; Perry DW; Mustard JF
    Thromb Haemost; 1976 Nov; 36(2):360-75. PubMed ID: 827032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced increases in cytosolic Ca2+ in ADP-stimulated platelets from patients with delta-storage pool deficiency--a possible indicator of interactions between granule-bound ADP and the membrane ADP receptor.
    Lages B; Weiss HJ
    Thromb Haemost; 1997 Feb; 77(2):376-82. PubMed ID: 9157599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidic acid releases calcium from a platelet membrane fraction in vitro.
    Gerrard JM; Butler AM; Peterson DA; White JG
    Prostaglandins Med; 1978 Nov; 1(5):387-96. PubMed ID: 103107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anionic lipids and accumulation of Ca2+ by a Ca(2+)-ATPase.
    Dalton KA; Mall S; Pilot JD; East JM; Lee AG
    Biochem Soc Trans; 1998 Aug; 26(3):S234. PubMed ID: 9765953
    [No Abstract]   [Full Text] [Related]  

  • 18. A new class of drugs that inhibit platelet release and aggregation.
    Shulman NR; Pollard HB; Tack-Goldman K; Buda E
    Trans Assoc Am Physicians; 1978; 91():104-17. PubMed ID: 38555
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcium diphosphatidate membrane traversal is inhibited by common phospholipids and cholesterol but not by plasmalogen.
    Chauhan A; Chauhan VP; Brockerhoff H
    Biochim Biophys Acta; 1988 Mar; 938(3):353-60. PubMed ID: 3349070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of phospholipids on platelet electrophoretic mobility.
    Hampton JR; Bolton CH
    J Atheroscler Res; 1969; 9(2):131-9. PubMed ID: 5770396
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.